摘要：近日，《印度时报》《今日印度》《政治家报》等7家印度主流媒体代表团到访厦门大学附属心血管病医院（简称“厦心医院”），深入了解医院医疗事业和国际合作等领域发展成就，并在印度主流报纸刊发专题报道。中央广播电视总台亚非中心、中国日报亚太分社及福建日报、福建电视台等多
近日，《印度时报》《今日印度》《政治家报》等7家印度主流媒体代表团到访厦门大学附属心血管病医院（简称“厦心医院”），深入了解医院医疗事业和国际合作等领域发展成就，并在印度主流报纸刊发专题报道。中央广播电视总台亚非中心、中国日报亚太分社及福建日报、福建电视台等多家媒体记者，以及正在厦心医院接受“心苗”访问学者计划培训的印度医师Mukesh Jha陪同参访。
厦心医院王焱院长带领代表团一行深度参观了医院，向客人们详细介绍了医院的发展规划、诊疗服务、学科建设、金砖合作及国际化发展等方面情况。在门诊大厅、医技检查区、二期沙盘、介入导管室、心苗计划学员墙、无陪护病房及胸痛中心等处，媒体代表们不时驻足，举起手机拍摄并现场采访。印度客人们对厦心医院国际一流的就医环境、医疗设施、服务理念、学科发展和国际化视野表示惊叹，深切感受到中国医疗事业的高速发展，并表达了希望推动中印心血管学科交流合作的热切期盼。
座谈交流环节，王焱院长向媒体代表们详细介绍了厦心医院在医工创新以及国际合作方面的主要成就：开展全球首例机器人辅助介入二尖瓣修复术等多项创新器械研发项目；成立金砖心血管健康创新中心；与印度阿波罗医院签署合作协议并常态化开展学术交流合作；参与印度Meril公司经导管主动脉瓣膜产品临床研究；“心苗”访问学者计划累计接收3位印度医师来院培训等。印度客人们高度认可厦心医院的产业化及国际化合作的突出成果，并就心脏瓣膜手术机器人、“心苗”访问学者计划等感兴趣话题踊跃提问和热烈讨论。
5月4日，印度《政治家报》（The Statesman）刊发专题报道《厦门心脏手术机器人创新：心血管医学的变革者》，以“国际领先”、“具有世界影响力”等关键词，介绍中国厦门大学附属心血管病医院发展情况、先进的瓣膜手术机器人系统以及“心苗”访问学者计划。
Delegation of Leading Indian Media Visited Xiamen Cardiovascular Hospital and Published Special Reports in Authoritative Indian Newspapers
Recently, delegations from seven major Indian media outlets, including Time of India, India Today, and The Statesman, visited Xiamen Cardiovascular Hospital Xiamen University (referred to as “XMCH”). They conducted in-depth explorations of the hospital’s achievements in medical development and international cooperation, and subsequently published special reports in mainstream Indian newspapers. Journalists from China Media Group Asia-Africa Center, China Daily Asia-Pacific Bureau, Fujian Daily, and Fujian TV Station, as well as Indian doctor Mukesh Jha—currently participating in the Heart Sapling Visiting Scholar Program at XMCH—accompanied the delegation on the visit.
President Wang Yan of XMCH led the delegation on a comprehensive tour of the hospital and gave detailed briefings on the hospital's development strategy, clinical services, discipline building, BRICS cooperation, and internationalization efforts. At locations such as the outpatient hall, medical technology inspection area, Phase II project model, interventional catheterization lab, Heart Sapling Scholar Wall, unaccompanied wards, and the Chest Pain Center, the media representatives frequently paused to take photos and conduct interviews. The Indian guests expressed amazement at the hospital’s world-class medical environment, facilities, service philosophy, academic growth, and global vision. They deeply felt the rapid advancement of China’s healthcare industry and conveyed strong hopes to promote Sino-Indian collaboration in cardiovascular medicine.
During a discussion session, President Wang introduced in detail the hospital’s major achievements in medical-technology innovation and international cooperation. These include conducting the world’s first robot-assisted transcatheter mitral valve repair, developing numerous innovative medical devices, establishing the BRICS Cardiovascular Health Innovation Center, signing a cooperation agreement with Apollo Hospitals in India to promote regular academic exchanges, participating in clinical studies of transcatheter aortic valve products by India’s Meril company, and receiving three Indian doctors to date for training under the Heart Sapling Visiting Scholar Program. The Indian guests highly praised the hospital’s achievements in commercialization and international cooperation, and engaged in enthusiastic discussions and questions on topics such as the transcatheter valve therapy robot and the Heart Sapling Program.
On May 4, The Statesman of India published a special report titled “Xiamen’s Robotic Heart Innovation: A Gamechanger in Cardiovascular Medicine”, highlighting terms like “internationally leading” and “globally influential” to describe the hospital’s development, its advanced valve surgery robot system, and the Heart Sapling Visiting Scholar Program.
来源：厦大附属心血管病医院
